CRNX - Citi starts Crinetics at buy cites upcoming data for lead drug
2024-03-06 11:53:55 ET
More on Crinetics Pharmaceuticals
- Crinetics: Paltusotine's Phase 3 Triumph Transforms Trajectory (Rating Upgrade)
- Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals
- Historical earnings data for Crinetics Pharmaceuticals
- Financial information for Crinetics Pharmaceuticals